Radio and PodcastRadio and PodcastLive Radio & Podcasts
JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC artwork
Science & Medicine

JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC

Journal of Clinical Oncology (JCO) Podcast by Journals Online Team

Nov 24, 202510:31Science & Medicine

In this episode of JCO Article Insights, host Dr. Ece Cali Daylan interviews author Dr. Jeffrey Bradley about the article, " Simultaneous Durvalumab and Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Can...